Roger Kirkwood
Psychiatric/Mental Health · Manhattan, KSNPI 1063728764
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,347 of the $5,609 with a category attached, or 77.5%. 18 manufacturers reported payments, led by Johnson & Johnson at 28.0% of the total. 2025 is the largest year on record at $2,996, 9.7 times the $308 reported in 2021. Among psychiatric/mental health clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 211 payments — averaging $26.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$928
- Takeda Pharmaceuticals U.S.A., Inc.$524
- Teva Pharmaceuticals USA, Inc.$441
- Axsome Therapeutics, Inc.$400
- Supernus Pharmaceuticals, Inc.$319
- plus $1K from 12 others
What the payments were for
- Travel & lodging$1,07919%
- Food & beverage$4,34777%
- Education$1833%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 17 | $1,570 |
| AbbVie | 47 | $928 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $524 |
| Teva Pharmaceuticals USA, Inc. | 24 | $441 |
| Axsome Therapeutics, Inc. | 13 | $400 |
| Supernus Pharmaceuticals, Inc. | 32 | $319 |
| Alkermes, Inc. | 15 | $301 |
| Otsuka America Pharmaceutical, Inc. | 7 | $216 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $200 |
| Lundbeck LLC | 8 | $160 |
| Collegium Pharmaceutical, Inc. | 3 | $156 |
| E.r. Squibb & Sons, L.L.C. | 3 | $122 |
| Neurocrine Biosciences, Inc. | 3 | $80 |
| Janssen Scientific Affairs, LLC | 2 | $68 |
| Tris Pharma Inc | 3 | $54 |
| Neos Therapeutics, LP | 2 | $37 |
| Corium, LLC | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,609 in reported general payments places this provider in the 90th percentile of 404 psychiatric/mental health providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 38 | $4,847 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 28 | $889 |
| Prazosin Hcl | 17 | $609 |
| Memantine Hcl ErMemantine Hcl | 13 | $449 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 14 | $379 |
| Benztropine Mesylate | 13 | $178 |
| Trazodone Hcl | 29 | $140 |
| Risperidone | 13 | $134 |
| Temazepam | 26 | $134 |
| Buspirone Hcl | 13 | $77 |
| Lorazepam | 30 | $77 |
| Alprazolam | 11 | $52 |
| Donepezil Hcl | 13 | $49 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Manhattan
- Eric ThomasonPittsburg$333K
- Belinda BagbyHutchinson$39K
- Hayley KnappWichita$31K
- Jennifer KubinBaldwin City$26K
- Uyen DinhPittsburg$20K
- Louise MuhoziKansas City$14K
- Theresa MuellerOverland Park$14K
- Shiney ZchariaOlathe$14K
- Deborah MurphyWichita$13K
- Marijen AgaShawnee$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.